Skip to content

Pontic Site Soft Tissue Augmentation Using De-epithelized Connective Tissue Graft Versus Partially De-epithelized Connective Tissue Graft

Assessment of Soft Tissue Profile After Pontic Site Development Using De-Epithelized Connective Tissue Graft Versus Partially De-Epithelized Connective Tissue Graft: A Randomized Controlled Clinical Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07434297
Enrollment
24
Registered
2026-02-25
Start date
2024-12-20
Completion date
2026-02-02
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pontic Site Development, Soft Tissue Augmentation

Brief summary

a comparative study to evaluate the pontic site soft tissue augmentation by partially de-epithelized connective tissue graft versus completely de-epithelized connective tissue graft (both grafts harvested from the hard palate). pontic site soft tissue augmentation allows the correction of soft tissue to allow proper fixed dental bridge fabrication (for esthetic and functional purposes)

Interventions

PROCEDUREIntervention

de-epithelized connective tissue graft for soft tissue augmentation for pontic site development

PROCEDUREControl

partially de-epithelized connective tissue graft for soft tissue grafting for pontic site development

Sponsors

October University for Modern Sciences and Arts
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* age 20-45 years * medically free * bounded missing teeth * patient accepting the fixed prosthetics as a treatment option * restorable adjacent abutments * periodontally healthy adjacent abutments * motivated patient to have the treatment * bleeding and plaque index less than 20%

Exclusion criteria

* systemic diseases * smoking * pregnancy * patients with pervious soft tissue grafting

Design outcomes

Primary

MeasureTime frame
keratinized tissue thicknesstime of enrollment, 3 and 6 months postoperative

Secondary

MeasureTime frame
soft tissue healing index6 months postoperative
Pain score3 and 7 days postoperative

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026